News for Nevro Corp. (NVRO)

PR NewswireREDWOOD CITY, Calif., March 4, 2025 REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device compan

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

PR NewswireMILWAUKEE, Feb. 24, 2025 MILWAUKEE, Feb. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fi

**media[546164]**

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read why I'm neutral on GMED stock.

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic stock transaction involving Nevro Corp (NVRO). The firm added 8,000 shares

On December 31, 2024, Western Standard LLC (Trades, Portfolio) made a significant move by acquiring an additional 138,200 shares of First Financial Northwest In

Transaction Overview On December 31, 2024, Shay Capital LLC (Trades, Portfolio) made a significant move by reducing its stake in Nevro Corp (NVRO). The firm dec

Engaged Capital exited stakes in BlackLine (BL), Nevro (NVRO), took a new position in Chart Industries (GTLS) in Q4 2024. Read more here.

Nevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GMED is set to acquire all shares of Nevro in an all-cash transaction, unlocking new growth opportunities.

Nevro (NVRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Globus Medical (GMED, Financials) agreed to acquire Nevro Corp. (NVRO, Financials) in an all-cash transaction valued at approximately $250 million. Globus will

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Nevro Corp. (NYSE: NVRO) to Globus Medical for $5.85 per share is fair to N

**media[534320,534321]**

**media[525352]**

Stryve Foods, Nevro, Canoo, MSA Safety and VTEX have been highlighted in this Screen of The Week article.